Add to bookmarks
Monitoring the Unmonitored

Early Detection of Patient Deterioration on the General Care Floor: Instituting Effective Vital Sign Monitoring

Speakers

  • Image
    Carla Jungqvist
    Carla Jungquist, PhD, ANP-BC, FAAN
  • Image
    Meera Joshi
    Meera Joshi, PhD, MBBS, MRCS

Unexpected adverse events resulting in transfer to the ICU occur in up to 9% of patients on the general care floor (GCF). Changes in ventilation have been found to be a key sign of patient deterioration. Early detection of respiratory insufficiency is key as for every hour of delay in detecting patient deterioration on the GCF increases the risk of death in the ICU by 1.5% and mortality by 1%. This webinar will describe the current evidence and cost savings associated with continuous respiratory monitoring on the general care floor.

For CE credits, if you are from the US and already watched the webinar live, please click here.

LEARNING OBJECTIVES:

Upon completion of this webinar, the participant will be able to:

  • Recognize signs and symptoms of patient deterioration.
  • Discuss the limitations of current monitoring on general medical and surgical ward.
  • Discuss the emergence of new technologies that may be a possible solution.
  • Evaluate the cost effectiveness of implementing continuous respiratory monitoring on the general care floor.
  • Interpret and apply data from various studies of patient centric respiratory monitoring devices in detecting patient deterioration

 

FEATURED SPEAKERS:

Carla Jungqvist

Carla Jungquist, PhD, ANP-BC, FAAN

Dr. Jungquist is an associate professor at the University at Buffalo School of Nursing and a Nurse Practitioner at Thompson Health Sleep Disorders Center. Her research endeavors are directed at safe and effective pain management. In particular, the application of continuous electronic respiratory monitoring to improve patient safety. She is the lead writer of the American Society for Pain Management Nursing clinical practice guidelines for identifying and monitoring patients at risk of opioid induced respiratory depression.

Meera Joshi

Meera Joshi, PhD, MBBS, MRCS

Dr. Joshi is Specialist Registrar at Ashford & St Peters Hospital in the KSS Deanery. She is Clinical Research Fellow in the department of Surgery and Cancer at Imperial College London. She has recently completed a PhD on ‘Optimising the identification of acute deterioration and sepsis through digital technology. Dr. Joshi has received several awards for her work including; the prestigious British Science Association Isambard Kingdom Brunel Award Lecture 2020, the Royal College of Surgeons England Research Fellowship and winner of the London Surgical Symposium. She has peer reviewed publications on wearable sensors and has been invited to present her work at several international meetings.

Continuing Education for Physicians, Nurses and Respiratory Therapists:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians. SynAptiv designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Saxe Healthcare Communications is accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477 and the Florida Board of Nursing Provider # 50-17032 This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care.

Advances in Patient Safety is provided by Saxe Healthcare Communications and is sponsored by GE Healthcare.

Ward Monitoring

Paint a future of secure, comprehensive monitoring for the ward

  • Respiratory
  • Respiration rate
  • Subacute care
  • Clinical